Q&A With Jens Nielsen From Aarhus University Hospital: MANTRA-PAF Trial Results 5 Years Later for Paroxysmal Atrial Fibrillation Treatment

Video

The MANTRA-PAF trial, A study looking at a treatment for paroxysmal atrial fibrillation reached its five year follow-up mark and the results were shared at the recent European Society of Cardiology Congress to see whether surgical or pharmaceutical treatment was better for patients.

The MANTRA-PAF trial, A study looking at a treatment for paroxysmal atrial fibrillation reached its five year follow-up mark and the results were shared at the recent European Society of Cardiology Congress to see whether surgical or pharmaceutical treatment was better for patients.

Jens Cosedis Nielsen, DMSc, PHD, from Aarhus University Hosptial discussed the results of the second round of follow ups during the European Society of Cardiology's annual conference in London. Nielsen said that while the results of the two treatment options were similar after 2 years, by the 5 year mar patients who had undergone the surgical option showed better results.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
Heart Failure stock imagery. | Credit: Fotolia
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Building a Psoriasis Knockout Regimen Around Risankizumab, with Andrew Blauvelt, MD, MBA
© 2024 MJH Life Sciences

All rights reserved.